Aller au contenu principal
Profil bibliographique

Chengchuang Zhan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

12Publications signalées
250Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Atrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmiasCardiac Ischemia and ReperfusionHydrogen's biological and therapeutic effectsAsthma and respiratory diseases

Les publications récentes

Accès ouvert 2025 article OpenAlex

Hydrogen alleviates right ventricular hypertrophy by inhibiting ferroptosis via restoration of the Nrf2/HO-1 signaling pathway

Juncai Bai, Hongxiao Yang, Chengchuang Zhan, Luqi Zhao et autres

BACKGROUND Right ventricular hypertrophy (RVH) occurs because of volume or pressure overload within the right ventricular (RV) system. RVH is associated with complex pathological changes, including myocardial cell injury, apoptosis, myocardial fibrosis, neuroendocrine disturbances, and abnormal water and liquid metabolism. Ferroptosis, a …

cn (code pays fourni par la source)

2 citations World Journal of Cardiology
Accès ouvert 2023 article OpenAlex

Case report: Persistent ST-segment elevation due to cardiac metastasis from lung cancer

Jiawei Zhou, Chengchuang Zhan, Jing Zhou, Chao Wei et autres

Patients with secondary cardiac cancer occasionally show ST segment elevation that mimics acute coronary syndrome despite the absence of coronary artery occlusion. We herein describe a rare case of secondary cardiac cancer that presented with ST-segment elevation. An 82-year-old Chinese man was …

cn (code pays fourni par la source)

5 citations Frontiers in Cardiovascular Medicine
Accès ouvert 2023 article OpenAlex

Vericiguat reduces electrical and structural remodeling in a rabbit model of atrial fibrillation

Qi Lou, Luyifei Li, Guangzhong Liu, Tiankai Li et autres

Purpose: The molecular etiology of atrial fibrillation (AF) and its treatment are poorly understood. AF involves both electrical and structural features. Vericiguat can ameliorate cardiac remodeling in heart failure. The effects of vericiguat on AF, however, are unclear. Here, the actions of …

cn (code pays fourni par la source)

14 citations Journal of Cardiovascular Pharmacology and Therapeutics
Accès ouvert 2022 article OpenAlex

[Retracted] Effects of Sacubitril/Valsartan on the Expression of CaMKII/Cav1.2 in Atrial Fibrillation Stimulation Rabbit Model

Qi Lou, Luyifei Li, Guangzhong Liu, Chengchuang Zhan et autres

Background and Objective . Atrial fibrillation (AF) is linked to high morbidity and death rates throughout the world due to limited therapeutic options and thus presents a major challenge to the developed and developing countries. In this study, we aim to investigate …

cn (code pays fourni par la source)

2 citations BioMed Research International
Accès ouvert 2021 article OpenAlex

Detection of circRNA Biomarker for Acute Myocardial Infarction Based on System Biological Analysis of RNA Expression

Wen Yang, Li Sun, Xun Cao, Luyifei Li et autres

Acute myocardial infarction (AMI) is myocardial necrosis caused by the persistent interruption of myocardial blood supply, which has high incidence rate and high mortality in middle-aged and elderly people in the worldwide. Biomarkers play an important role in the early diagnosis and …

cn (code pays fourni par la source)

20 citations Frontiers in Genetics
2019 article OpenAlex

Chronic B-Type Natriuretic Peptide Therapy Prevents Atrial Electrical Remodeling in a Rabbit Model of Atrial Fibrillation

Hongyan Zhao, Tiankai Li, Guangzhong Liu, Li Zhang et autres

Background: Atrial fibrillation (AF) is an important and growing clinical problem. Current pharmacological treatments are unsatisfactory. Electrical remodeling has been identified as one of the principal pathophysiological mechanisms that promote AF, but there are no effective therapies to prevent or correct electrical …

cn, us (code pays fourni par la source)

7 citations Journal of Cardiovascular Pharmacology and Therapeutics
Accès ouvert 2016 article OpenAlex

Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR‐α/sirtuin 1/PGC‐1α pathway

Guangzhong Liu, Tingting Hou, Yue Yuan, Pengzhou Hang et autres

BACKGROUND AND PURPOSE: Atrial metabolic remodelling is critical for the process of atrial fibrillation (AF). The PPAR-α/sirtuin 1 /PPAR co-activator α (PGC-1α) pathway plays an important role in maintaining energy metabolism. However, the effect of the PPAR-α agonist fenofibrate on AF is …

cn (code pays fourni par la source)

91 citations British Journal of Pharmacology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.